1. Digoxin use increases mortality risk in patients with systolic HF

   Epidemiology population study 05 October 2013 Pages: 1 - 1

2. FDA mandates labelling colour change for fentanyl patch

   News item 05 October 2013 Pages: 2 - 2

3. MHRA looks to simplify incident reporting

   News item 05 October 2013 Pages: 2 - 2

4. WHO calls for post-reg surveillance to be part of African initiative

   News item 05 October 2013 Pages: 2 - 2

5. Rituximab, ofatumumab boxed warning of HBV reactivation risk

   News item 05 October 2013 Pages: 3 - 3

6. New boxed warning for Tygacil

   News item 05 October 2013 Pages: 3 - 3

7. Aggression with tapentadol, an apparent signal

   Incidence study 05 October 2013 Pages: 3 - 3

8. Genetic screening for contraceptive-induced VTE

   Clinical study 05 October 2013 Pages: 4 - 4

9. Balancing postoperative risks: ulcers versus pneumonia

   Epidemiology population study 05 October 2013 Pages: 4 - 4

10. Varenicline not linked to depression, anxiety in smokers

    Clinical study 05 October 2013 Pages: 4 - 4

11. Adalimumab

    Case report 05 October 2013 Pages: 5 - 5

12. Alitretinoin

    Case report 05 October 2013 Pages: 5 - 5

13. Acetazolamide/phenytoin

    Case report 05 October 2013 Pages: 5 - 5

14. Aciclovir

    Case report 05 October 2013 Pages: 5 - 5

15. Amisulpride

    Case report 05 October 2013 Pages: 6 - 6

16. Amisulpride

    Case report 05 October 2013 Pages: 6 - 6

17. Amiodarone/citalopram/linezolid

    Case report 05 October 2013 Pages: 6 - 6

18. Amiodarone

    Case report 05 October 2013 Pages: 6 - 6

19. Amlodipine

    Case report 05 October 2013 Pages: 7 - 7

20. Antipsychotics/benzatropine/laxatives

    Case report 05 October 2013 Pages: 7 - 7

21. Antineoplastics

    Case report 05 October 2013 Pages: 7 - 7

22. Antineoplastics

    Case report 05 October 2013 Pages: 7 - 7

23. Antiretrovirals/metformin

    Case report 05 October 2013 Pages: 8 - 8

24. Antiretrovirals

    Case report 05 October 2013 Pages: 8 - 8

25. Antituberculars

    Case report 05 October 2013 Pages: 8 - 8

26. Benzylthiouracil

    Case report 05 October 2013 Pages: 9 - 9

27. Asenapine

    Case report 05 October 2013 Pages: 9 - 9

28. Azathioprine

    Case report 05 October 2013 Pages: 9 - 9

29. Bivalirudin

    Case report 05 October 2013 Pages: 10 - 10

30. Bevacizumab

    Case report 05 October 2013 Pages: 10 - 10

31. Bevacizumab

    Case report 05 October 2013 Pages: 10 - 10

32. Bevacizumab

    Case report 05 October 2013 Pages: 10 - 10

33. Boceprevir/peginterferon-α-2b/ribavirin

    Case report 05 October 2013 Pages: 10 - 10

34. Calcipotriol

    Case report 05 October 2013 Pages: 11 - 11

35. Calcium polystyrene sulfonate

    Case report 05 October 2013 Pages: 11 - 11

36. Ceftriaxone

    Case report 05 October 2013 Pages: 11 - 11

37. Celecoxib

    Case report 05 October 2013 Pages: 11 - 11

38. Carbamazepine

    Case report 05 October 2013 Pages: 11 - 11

39. Cisplatin/etoposide/lenograstim

    Case report 05 October 2013 Pages: 12 - 12

40. Cetuximab/gefitinib

    Case report 05 October 2013 Pages: 12 - 12

41. Ciclosporin/rifampicin interaction

    Case report 05 October 2013 Pages: 12 - 12

42. Cisplatin/fluvoxamine

    Case report 05 October 2013 Pages: 12 - 12

43. Citalopram

    Case report 05 October 2013 Pages: 13 - 13

44. Cisplatin/irinotecan

    Case report 05 October 2013 Pages: 13 - 13

45. Clindamycin

    Case report 05 October 2013 Pages: 13 - 13

46. Clarithromycin/pentamidine

    Case report 05 October 2013 Pages: 13 - 13

47. Codeine/paracetamol

    Case report 05 October 2013 Pages: 14 - 14

48. Clozapine

    Case report 05 October 2013 Pages: 14 - 14

49. Clozapine

    Case report 05 October 2013 Pages: 14 - 14

50. Colchicine overdose

    Case report 05 October 2013 Pages: 14 - 14